Diclona Gel
Product Images NDC 83881-102

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Diclona (NDC 83881-102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Clinic Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Carton Box (Diclona Box 053124 (1))

Carton Box (Diclona Box 053124 (1))
FDA Label Image

Back (Diclona Package Insert Gsc 102424 Back (1))

Back (Diclona Package Insert Gsc 102424 Back (1))
This text provides detailed information on the distribution, metabolism, excretion, indications, contraindications, warnings, precautions, and drug interactions of a medication called Diclona™ for relieving pain associated with various conditions like arthritis, backache, discomfort, and sprains. It discusses the risks of serious conditions such as methemoglobinemia, cardiovascular events, fetal toxicity, and skin reactions. The text also advises on precautions such as avoiding eye exposure, use in patients with heart failure, and caution in patients with gastrointestinal ulceration or hepatic impairments. Additionally, it mentions the lack of studies on fertility, pregnancy, labor, and breastfeeding effects of Diclona™, and the need for caution in pediatric and geriatric populations.*
FDA Label Image

Package Insert (Front)

Package Insert (Front)
This document provides detailed information on the dosage and administration of Diclona™, a gel containing Lidocaine (4.5%) and Diclofenac Sodium (1%). It includes instructions on how to apply the product, safety measures, handling, and disposal instructions. Additionally, it discusses adverse reactions, systemic reactions, overdosage risks, drugs that may cause methemoglobinemia when used with Diclona™, and clinical pharmacology information regarding pharmacodynamics and pharmacokinetics. The product should be kept out of reach of children, and contact with eyes should be avoided. For further information, the manufacturer, Clinic Pharma, can be contacted via email.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.